Explores bacterial outer membrane vesicles to boost immune response in tumors, suggesting significant therapeutic potential.
Outer membrane vesicles (OMVs) have emerged as highly promising bio-derived nanoplatforms in tumor immunotherapy due to their inherent immunogenicity, structural diversity, and molecular customization capabilities. Recent studies have introduced various...
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: